Clinical trials are an integral component of healthcare research, providing a platform to test new drugs, procedures, and medical devices before they become available to the public. These trials are essential for evaluating the safety and efficacy of treatments, identifying potential side effects and risks, and enhancing patient outcomes. With thousands of clinical trials conducted worldwide, covering diverse health conditions ranging from cancer to rare genetic disorders, the potential to transform healthcare and improve lives globally is immense.
CURRENT CLINICAL TRIALS WITH SKIN CANCER & DERMATOLOGY INSTITUTE
Abbvie M19-977, enrolling adolescents with moderate to severe psoriasis,
Amgen 20210143, enrolling adults with moderate to severe atopic dermatitis,
and Amgen 20210145, enrolling adolescents with the same condition.
Castle is an observational study aiming to identify genetic markers and patient response to systemic meds.
The Sotyktu study aims to collect quality-of-life data for patients with moderate to severe psoriasis needing a biologic.
If you are interested in referring a patient or learning more about participating in a clinical trial, please contact us at 775.336.3665.
All study participants receive free drugs and compensation for their visits. Joining a clinical trial is an excellent way to contribute to medical research and help advance healthcare for everyone.